ABSTRACT Background: The consumption of prebiotics (fermentable and nondigestible carbohydrates) has been proposed as a potentially protective factor against overweight and obesity. However, to our knowledge, no previous prospective studies have assessed the association between the consumption of prebiotics and the incidence of overweight or obesity. Objective: We evaluated the association between prebiotic consumption [fructans and galacto-oligosaccharides (GOSs)] and the incidence of overweight [body mass index (BMI; in kg/m 2 ) $25] in the SUN (Seguimiento Universidad de Navarra) Project, which is a prospective cohort of Spanish, middle-aged university graduates with initial BMI ,25. Design: The SUN Project is a dynamic, prospective, multipurpose cohort of Spanish university graduates with an overall retention rate of 90%. The study population encompassed 8569 Spanish university graduates (mean age: 37 y) who were initially free of overweight or obesity. Self-reported weight (previously validated) was collected at baseline and updated every 2 y during the followup period. Fructan consumption and GOS consumption were assessed with the use of a validated semiquantitative 136-item food-frequency questionnaire and were updated after 10 y. Time-dependent Cox proportional hazards models were used to estimate HRs and 95% CIs for incident overweight and to adjust for potential confounding factors. Results: During follow-up (median: 9 y), 1964 incident cases of overweight were identified. After potential confounders were adjusted for, risk of overweight was 15% lower in participants in the highest quartile of fructan consumption ($2.3 g/d) (95% CI: 0.74, 0.97; P-trend = 0.019). Subjects in the highest quartile of GOS consumption ($0.45 g/d) had 17% lower risk of overweight (95% CI: 0.74, 0.94; P-trend = 0.001). Conclusions: Higher prebiotic consumption was associated with lower risk of overweight in a cohort of initially normal-weight, middle-aged adults. This potential protection has been previously scarcely assessed; therefore, additional longitudinal studies are needed to confirm our results.
INTRODUCTION
Obesity is a global public health problem that increases risk of cardiovascular diseases, cancer, or premature death (1) . Although obesity is a multifactorial disease that is mainly caused by an energy imbalance between calories consumed and calories expended, the consumption of specific foods and nutrients may also play important roles (2, 3) . A growing body of evidence has supported a role for dietary fiber with prebiotic properties in modulating host gene expression and metabolism by producing changes in the composition and activity of the gut microbiota (4, 5) . Some studies have indicated that an altered gut microbiota is associated with several noncommunicable diseases such as obesity and its related metabolic disorders (6, 7) .
The term prebiotic has been defined as "a selectively fermented ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microflora that confers benefits upon host wellbeing and health" (8) . Prebiotics have been mainly categorized into the following 2 groups on the basis of their chemical structures: the fructans (fructo-oligosaccharides and inulin) and the galacto-oligosaccharides (GOSs) 5 (9) . These prebiotics, which are present in various fruit, vegetables, and whole grains, increase the intestinal growth of beneficial bacteria for human health (e.g., Bifidobacteria and Lactobacilli), whereas they can reduce the presence in the gut of some pathogenic bacteria subpopulations (e.g., Clostridium difficile or Enterobacteriaceae) (5) . The potential beneficial effects of prebiotic consumption include an improvement of the gut barrier function and host immunity, the prevention of antibiotic-associated diarrhea, favorable changes in lipid metabolism, calcium absorption, and bone health, and a potential preventive role against colon cancer (10, 11) . There has also been a growing interest in the effects of prebiotics on glycemic control, weight loss, and satiety (11, 12) .
Although most of the results in support of the beneficial effects of prebiotics on obesity and its comorbidities have come from animal studies, there have also been some human randomized controlled trials that have supported this hypothesis. For example, decreases in inflammatory and metabolic syndrome (MetS) markers were observed in adults with the MetS when their diets were supplemented with GOSs (13) . Prebiotics may also regulate food intake and increase satiety by increasing the postprandial release of gut peptides (namely glucagon-like peptide-1 and gastric inhibitory peptide) and by decreasing postprandial glycemia (6, 15) . Therefore, their role in the prevention and treatment of obesity has attracted much interest in recent years.
However, to our knowledge, no previous epidemiologic study has assessed the role of prebiotics on the incidence of overweight in a large prospective cohort. Therefore, our aim was to investigate the relation between prebiotic (fructans and GOS) consumption and the incidence of overweight [BMI (in kg/m 2 ) $25] in middle-aged adults with low BMI at baseline who were participating in the SUN (Seguimiento Universidad de Navarra) Project.
METHODS

Subjects
The SUN Project is an ongoing, multipurpose, prospective, and dynamic cohort composed of Spanish university graduates. The design, methods, and objectives of this project have been described previously (16) . Briefly, the recruitment of participants started in December 1999, and self-administered questionnaires are sent by mail every 2 y with important questions to evaluate changes in lifestyle and health factors.
To ensure that all participants had the opportunity to answer the 2-y follow-up questionnaire, only 21,291 participants who had answered the baseline questionnaire before March 2012 were considered eligible (Figure 1 ). For the current longitudinal analysis we selected only participants with baseline BMI ,25 and excluded 6340 participants with prevalent overweight at baseline. Participants who reported total energy intakes at baseline out of recommended limits (total energy intakes .4000 and .3500 kcal/d in men and women, respectively, and ,800 kcal/d in men and ,500 kcal/d in women) (n = 1532) (17) , women who were pregnant at baseline or got pregnant during the follow-up period (n = 2791), 626 participants who, at baseline, reported a prevalent or previous chronic disease (diabetes, cardiovascular disease, and cancer), and 263 subjects with a weight change .10 kg in the 5 y preceding entry into the study were also excluded to reduce the potential source of confounding by other causes of weight changes. Of the remaining participants, 1106 subjects were lost to follow-up (retention rate: 90%), and 64 participants had missing values in at least one of the variables of interest. Finally, 8569 participants were included in our main longitudinal analysis.
The study was conducted according to the Declaration of Helsinki, and the protocol was approved by the Institutional Review Board of the University of Navarra. Informed consent was implied by the voluntary completion of the first questionnaire. 
Exposure assessment
Dietary exposures were assessed at baseline and after 10 y of follow-up with the use of a self-administered 136-item semiquantitative food-frequency questionnaire (FFQ), which was previously validated in Spain (18) . Each item in the FFQ included a typical portion size. Daily food consumption was estimated by multiplying the portion size by the consumption frequency for each food item (9 options ranging from never or almost never to $6 times/d). Because the amounts of fructans (fructo-oligosaccharides and inulin) and GOSs in food are not currently available in food-composition tables, the grams of prebiotics per 100 g were obtained from articles that have quantified fructans (19) (20) (21) and GOSs (20, 22) . When 2 articles presented different estimates of the grams of prebiotics, we used the mean of both estimates. A total of 37 items of the FFQ had values for fructans and GOSs. We used dietary intakes from the FFQ to calculate total fructan and GOS intakes and updated these values with the use of the 10-y follow-up dietary assessment. The percentage of subjects who completed 2 FFQs was 26.9%. This percentage was low because of the dynamic design (i.e., recruitment is permanently open) and late entry in the cohort. Total prebiotic consumption was calculated by the sum of fructan and GOS intakes.
Outcome assessment
Weight and height were self-reported by participants at baseline and every 2 y of follow-up. BMI was calculated as weight divided by the square of height, which was ascertained at baseline. Selfreported weight and BMI have been previously validated in this cohort (23) . Incident cases of overweight and obesity were defined as those participants with BMI ,25 at baseline and BMI $25 during follow-up.
Ascertainment of covariates
With consideration that risk of overweight is determined by several factors, several covariates were used for adjustments from the baseline questionnaire, including anthropometric, sociodemographic, lifestyle, and medical variables. Physical activity was evaluated with the use of a validated 17-item questionnaire (24) . Adherence to the Mediterranean dietary pattern was evaluated with the use of a well-known score (25) .
Statistical analyses
Participants were classified into sex-specific quartiles according to their fructan, GOS, and total prebiotic (sum of fructan and GOS) intakes at baseline, which were updated after 10 y of follow-up.
To evaluate whether the consumption of prebiotics at baseline was associated with the development of overweight over the follow-up time, we used Cox proportional hazards models to estimate HRs and their 95% CIs with the use of the lowest category as the reference. Prebiotic data were updated after 10 y of follow-up. The follow-up time was defined as the interval between the date of recruitment to the date of the return of that follow-up questionnaire in which the participant entered in the category of overweight for the first time (for incident cases), the date of death, or the date of the last questionnaire for noncases.
The Cox model included age as the underlying time variable for all analyses. Multivariable models were adjusted for sex, baseline BMI, physical activity, unemployment, previous history of depression, sleeping hours, sleeping siesta, fast-food consumption (sum of hamburger, sausage, and pizza consumption), sugarsweetened-beverage consumption, fried-food consumption, sitting hours, smoking (never, current, or former), snacking between meals, following a special diet, total energy intake, living alone, and marital status. Tests of linear trend across increasing quartiles of fructan, GOS, and total prebiotics intakes were conducted by assigning medians to each category and treating them as continuous variables in the respective Cox regression model. Analyses were stratified by the calendar date of recruitment (2-y periods) and deciles of age. Nelson-Aalen plots were constructed, and tests of time-varying covariates were performed, to confirm that the data conformed to the assumption of proportional hazards.
We constructed a series of nested least-squares linear regression models after stepwise-selection regression analyses with the use of the outcome of the consumption of prebiotics to determine the contribution of each food item to the between-person variance for prebiotic consumption (17) . The additional contribution of a given food item was reflected in the increase in cumulative R
.
We fit a generalized estimating equation linear model to examine the association between baseline prebiotic consumption and average BMI over time, which were updated in each biennial follow-up questionnaire. Time was modeled as a continuous variable. An interaction between time and prebiotic consumption was also included, but it was NS (P = 0.410). The covariance structure assumed was interchangeable. Absolute means adjusted for all the potential confounders described above in the Cox models, including baseline BMI, and 95% CIs were reported for the first and fourth quartiles of prebiotic consumption at baseline, and they were graphically represented. Because of the dynamic design of the cohort (i.e., continually open recruitment) and to avoid a lack of statistical power because there were only a small number of subjects who were candidates to complete the questionnaires for the 12-y and 14-y follow-up assessments (only possible for those who entered the cohort before 2002), the association between baseline prebiotic consumption and biennially updated values of BMI was truncated after 10 y of follow-up.
We evaluated the interaction of sex and a previous tendency for weight gain ($3 kg in the previous 5 y before entering the cohort) with prebiotic intake on the development of overweight with the use of likelihood ratio tests that compared the fully adjusted Cox regression model and the same model with interaction product terms (3 df that corresponded to the 3 upper quartiles).
Last, to explore the robustness of the associations, we conducted several sensitivity analyses by rerunning all the multivariable-adjusted Cox regression models under different assumptions as follows: 1) with the inclusion of subjects with prevalent chronic diseases; 2) with the inclusion of participants with energy limits between fifth and 95th percentiles; 3) with the exclusion of participants aged .65 y; 4) with additional adjustment for adherence to the Mediterranean dietary pattern; 5) with inclusion in the multiple-adjusted model of a personal history of obesity; 6) with adjustment for the consumption of other types of fiber; 7-9) after additional adjustments for the following main sources of fiber intake in SUN-cohort participants: nuts, beans, and chard; 10) after additional adjustment for banana consumption; 11) after additional adjustment for weight gain $3 kg in the 5 y before to entering the cohort; and 12) with the exclusion of participants who were early incident cases of overweight (those who became overweight only after 2 y of follow-up).
All P values were 2-tailed, and P , 0.05 was considered significant. Statistical analyses were performed with the use of STATA version 12.0 software (StataCorp LP).
RESULTS
The main characteristics of the 8569 participants categorized by baseline quartiles of total prebiotic consumption are presented in Table 1 . Compared with participants in the first quartile, those in the fourth quartile of prebiotic intake were more likely to be women, older, nonsmokers, and physically more active. On average, participants in the fourth quartile had higher total energy and total fiber intakes and a higher consumption of fried foods but less sugar-sweetened-beverage intake. Also, they were less prone to have gained $5 kg in the past 5 y, and their adherence to the Mediterranean diet was higher.
During a median time of 9 y of follow-up, we documented 1964 incident cases of overweight. HRs and 95% CIs for overweight associated to prebiotic (fructan and GOS) consumption are shown in Table 2 . Participants with higher consumption of fructans (.2.3 g/d; highest quartile) presented significantly 15% lower risk of overweight than for subjects in the lowest quartile (adjusted HR: 0.85; 95% CI: 0.74, 0.97) with a significant linear trend (P = 0.019). We also observed a significant inverse association for GOS intake (.0.45 g/d; highest quartile) with a fully adjusted HR of 0.83 (95% CI: 0.74, 0.94; P-trend = 0.001). Moreover, participants in the third quartile of total prebiotic consumption (.2.1 g/d) also showed lower risk of overweight (adjusted HR: 0.86; 95% CI: 0.77, 0.97; P-trend = 0.012). Similar estimates were apparent in the upper quartile. The Nelson-Aalen cumulative hazard function (Figure 2 ) showed crude differences in the incidence of overweight by Mean 6 SD (all such values). 4 Sum of hamburger, sausage, and pizza consumption. 5 Equal to total fiber intake minus total prebiotic intake. quartiles of total prebiotic intake. These curves exhibited a lower incidence of overweight across increasing baseline quartiles of total prebiotic intake. No significant interaction between sex and prebiotic intake was observed (P-interaction = 0.825).
When we used generalized estimating equations to assess the association between prebiotic intake and biennially updated average BMI, we also showed significant differences in average BMI between extreme quartiles of prebiotic intake ( Figure 3) . The contribution of different food groups to total prebiotic intake as well as the main food contributors to fructan and GOS intakes are shown in Table 3 . Asparagus and both white bread and whole-grain bread were among the major contributors to prebiotic consumption. The likelihood ratio test, which was conducted to assess the interaction between a previous tendency for weight gain (before entering the cohort) and prebiotic intake, was NS (P = 0.679).
In our sensitivity analyses, we further adjusted for adherence to the Mediterranean diet, a personal history of obesity, other sources of fiber consumption, main sources of fiber in the cohort, banana consumption, and weight gain $3 kg in the 5 y before entering the cohort. We also repeated the Cox regression analysis by censoring participants who were early incident cases of overweight (2 y of follow-up) to minimize reverse causation. We also reran our analyses after the inclusion of subjects with prevalent cancer, diabetes, or cardiovascular disease, with energy limits between fifth and 95th percentiles and after the exclusion of subjects .65 y old. The association between total prebiotic consumption with risk of overweight lost significance in some of these analyses. However, independent of adjustments, the inverse association between fructans or GOSs and the incidence of overweight remained significant ( Table 4) .
DISCUSSION
In this prospective cohort study of Spanish middle-aged adults with initially low body weight, we observed that increased intake of prebiotics was associated with lower risk of developing overweight during follow-up after adjustment for potential confounders. RR reductions were similar for the upper quartiles of fructans (15%) or GOS (17%) consumption. To date, most of the studies that have studied the prebiotic-obesity relation have come from animal studies, and to our knowledge, this is the first prospective epidemiologic study to examine this association.
It is well known that higher fiber intake is a protective factor for the maintenance of healthy weight (26) . However, our results suggest that prebiotic consumption confers additional beneficial 1 Cox regression analysis of repeated measurements of diet with updated dietary values from the food-frequency questionnaire after 10 y of follow-up (10-y follow-up questionnaire). The multiple-adjusted model was adjusted for sex, age, baseline BMI, physical activity, unemployment, previous history of depression, sleeping siesta, fast-food consumption (sum of hamburger, sausage, and pizza consumption), sugar-sweetened-beverage consumption, fried-food consumption, sitting hours, smoking (never, current, and former), snacking between meals, following a special diet, total energy intake, sleeping hours, living alone, and marital status. Models were stratified by the date of recruitment (2-y periods) and deciles of age. SUN, Seguimiento Universidad de Navarra.
2 HR; 95% CI in parentheses (all such values). 3 Total prebiotic consumption was the sum of galacto-oligosaccharides and fructans. effects for weight management. Indeed, when we adjusted for other types of fiber consumption, the results were maintained.
Several mechanisms may explain these additional potential beneficial effects of prebiotic intake on overweight risk. Dietary fructans and GOSs are used as energy substrates by a number of bacteria, including Bifidobacteria, which can lead to an increase in the production of short-chain fatty acids (SCFAs) (mainly propionic and butyric acids) and lactate. Beyond being an energy source, SCFAs have been proposed to maintain colonic health and to have anti-inflammatory effects (11, 27, 28) . The role of propionic acid in human metabolism is not clear; although some studies have shown that propionic acid suppresses the fatty acid production in the liver and lipogenesis in the adipose tissue, other studies have revealed that excessive amounts of this fatty acid might be associated with neurologic disorders and low-grade inflammation (29, 30) . Butyric acid plays a critical role in the maintenance of intestinal homeostasis and may reduce low-grade inflammation, oxidative stress ,and cancer proliferation, thereby decreasing risk of obesity (31) . SCFAs might also suppress pro-inflammatory cytokines, which are of great importance for obesity-associated inflammation (32) . The production of SCFAs may also stimulate satiation although peptide YY and glucagon-like peptide 1 production, what may contribute to decreased food intake (15, 28) .
Prebiotic properties may counteract the overexpression of several genes and molecules implicated in the development of obesity through a decrease in adiposity, metabolic disorders, and low-grade inflammation (6) . Prebiotics may also increase stool frequency and weight. They also decrease luminal pH through the previously mentioned SCFA production and, in turn, inhibit the growth of potentially pathogenic Enterobacteriaceae (33). Moreover, some human randomized trials that included prebiotic supplements have exhibited their beneficial health effects. GOS administration to adults with MetS resulted in a decrease in C-reactive protein in blood and calprotectin in stool samples as well as improvements in MetS-related biomarkers such as insulin, total cholesterol, and triglycerides (13) . Oral inulin administration was also observed to decrease total cholesterol, LDL cholesterol, VLDL, and triglyceride blood concentrations in obese individuals (14) . Moreover, oligofructose supplementation promoted weight loss and improved glucose regulation in overweight adults, which was associated with a decrease in ghrelin and an increase in peptide YY (34) .
Other dietary factors have been suggested to affect the gut microbiota, and theoretically, their detrimental effect can be compensated with the benefits provided by prebiotics. Animal studies have shown that the consumption of high-fat diets reduced the formation of SCFAs while increasing succinate, low-grade inflammation, liver fat, and total cholesterol, indicating a detrimental effect of high-fat consumption (35) . Probiotics are also important for gut health (12) . In this Mediterranean cohort, the association between yogurt consumption and the incidence of overweight and obesity has been already examined and showed a significant inverse association (36) .
Strengths of the current study included a prospective design, high rates of long-term follow-up, a large sample size, and repeated measurements of the diet. This cohort also had published validation substudies for our methods and allowed for a sufficiently large induction period, which may have reduced the potential for reverse causation bias. All participants were university graduates, which minimized potential confounding by educational level and increased the quality of self-reported information. However, the current study also had several limitations. First, dietary assessment with the use of an FFQ is subject to measurement errors. Nevertheless, previously published validation studies have supported the appropriateness of its use in nutritional epidemiology (17) and in this particular cohort (18) . Second, other lifestyle factors may have affected the outcomes, and also, some prebiotic intakes might have been missed because our questionnaire was composed of 136-items, and therefore, it did not collect all possible foods that may contain prebiotics. ) as the outcome during 10 y of follow-up according to extreme Qs of total prebiotic consumption. The model was adjusted for sex, age, baseline BMI, physical activity, unemployment, depression at baseline, sleeping siesta, fast-food consumption (sum of hamburger, sausage, and pizza consumption), sugared soft-drink consumption, fried-food consumption, sitting hours, smoking (never, current, and former), snacking between meals, following a special diet, energy intake, sleeping hours, living alone, and civil status. GEE, generalized estimating equation; Q, quartile Cox regression analysis of repeated measurements of diet with updated dietary values from the food-frequency questionnaire after 10 y of follow-up. The multiple-adjusted model was adjusted for sex, age, baseline BMI, physical activity, unemployment, depression at baseline, sleeping siesta, fast-food consumption (sum of hamburger, sausage, and pizza consumption), sugar-sweetened-beverage consumption, fried-food consumption, sitting hours, smoking (never, current, and former), snacking between meals, following a special diet, energy intake, sleeping hours, living alone, and civil status. SUN, Seguimiento Universidad de Navarra. Third, although fructans and GOSs are the most important prebiotic sources, there are other prebiotics, such as lactulose or b-glucan, that were not included in this analysis because of the unavailability of sufficient data. In addition, the values of prebiotics used in this study were obtained from international sources because neither Spanish food-composition tables nor any Spanish scientific publications have analyzed the content of prebiotics present in Spanish typical foods. Fourth, this study did not collect stool samples from our participants, and therefore, the gut microbiota composition could not be determined. Fifth, we used a Cox proportional hazards model although this method is designed for events for which the time of occurrence is usually more accurate; however, this method has often been used when survival data were interval censored in studies of overweight or obesity in which the exact time of occurrence was not so well defined as in another disease status. Last, self-reported height and weight and the possible variability in adiposity in people with the same BMI might have been additional limitations of our study.
In conclusion, higher prebiotic consumption was associated with decreased risk of overweight in this Mediterranean cohort. These novel, prospective findings support the potential importance of prebiotic consumption in the development of obesity, which may be useful for the design of preventive and therapeutic dietary approaches for obesity management. However, additional longitudinal studies are needed to confirm our results. The authors' responsibilities were as follows-AP-C: wrote the manuscript; AP-C, MAM-G, and MB-R: designed the research; AP-C and IJ: conducted the research; AP-C and MB-R: analyzed the data and/or performed the statistical analysis and had primary responsibility for the final content of the manuscript; MAM-G and MB-R: were responsible for administrative support and funding; MR-C, SC, and CS-O: provided essential materials; and all authors: revised the manuscript for important intellectual content and read and approved the final manuscript. None of the authors reported a conflict of interest related to the study.
